Member Info for ForFXSake

Funnily enough, no I didn't bother clicking on a link to a paid report after reading through a plethora of names of companies developing IPF therapies and seeing no mention of Nuformix in the main article.

It was interesting to see that a company in China with an inhaled treatment had successfully been granted FDA approval.

Perhaps we'll get a mention next time, if the funds haven't run out.

I'm aware that it's 8 weeks since ODD ratification.

Where is the draft FDA submission?

Where are the partners?

I'm a little more interested at the moment in knowing what the enigmatic Dr Daniel Gooding is up to. He seems to have disappeared off the face of the earth!

Found this article about promising players in the IPF arena. It's from back in January, about the time we were about submit for ODD:

https://www.globenewswire.com/news-release/2025/01/28/3016700/0/en/Pulmonary-Fibrosis-Clinical-Trial-Pipeline-Appears-Robust-With-110-Key-Pharma-Companies-Actively-Working-in-the-Therapeutics-Segment-DelveInsight.html

Not a single mention of NXP002 or Nuformix.

How come we're not on anybodies radar after all this business development that's been going on?

Buyings fizzled out, looks like dumpers are getting twitchy again

"but your concerns are mostly speculative and don’t align with what the company has publicly stated."

NASA1, same goes for me. I completely respect your opinion and views and know nothing about what is to come. My concerns are based only on what I have seen.

To be fair, the company's public statements have also been mostly speculative and haven't yet aligned with many of the expectations that shareholders drew from them.

When NXP001 was announced as our most advanced asset (targeted at a CINV market worth hundreds of millions) for entry to phase 1, most shareholders never expected it would end up being side-lined and sold off for about £50k-£100k and a few measly milestones.

When they announced the NXP001 deal with Oxilio for cancer treatment, most shareholders expected us to retain the rights to continue to be able to develop NXP001 for our own use in CINV.

When they announced the deal with Oxilio, most shareholders thought we would get see some of those royalties (capped at £2m a year), which haven't yet materialised.

When they announced a £51m deal with Ebers, most shareholders didn't expect it to evaporate to nothing.

When they announced the Chinese NXP001 collaboration, most shareholders expected to get paid £2m that we were told we were owed.

Shareholders didn't expect the NXP004 blockbuster potential to be side-lined

When NXP002 ODD submission was made priority most shareholders expected ratification to quickly lead to a deal.

The list goes on.

If only they could deliver meaningful, tangible, lasting value on at least one thing that they have stated in the past, then all would be forgiven.

I'm not sure anyone is to blame Littlened, simply because I just don't know what the hell is really going on.

If the board is genuinely still talking to the same partners who were looking to make a deal on ODD ratification and those partners are still considering a deal but will offer better terms if we get FDA as well then I suppose all is still very good. However they should tell us when to expect that to be done.

If the same partners have gone back on their word and are now stalling for FDA approval without offering any more then I believe the board should be open with shareholders about it and offer them less protection and seek other partners instead. I would understand and support that decision as risky as it might be.

If they are no longer in discussions with partners who were offering a deal on ODD then the board should have made us aware of that. Again, it might not be their fault but hiding that fact from shareholders while raising funds is definitely not good.

Not sure what else you want

I'm so sorry to read about what your Dad and your family went through, Galadriel. I understand what it's like having been through a similar experience with a loved one we lost to COPD.

I understand your strength of feeling but it is simply not true to blanket every critic as someone who is attempting to do the company harm.

I'm regularly accused of being a deramper on here for criticising what I believe to be a lack of transparency by management or the pump and dump merchants who scare of real investment but you're wrong if you think my intention is to harm the company.

I've held my shares here since I first bought in back in 2019. I wasn't awarded those shares, like some ex-directors who have since sold, I bought them with my own money. I've stuck with it through thick and thin, hoping for someone to make it work. I've seen every director (except for Julian & Maddy) walk away from the company at some point. I've seen contracts evaporate into thin air. I've seen promising assets such as NXP001 sold off in order to progress NXP002. I've been told we're in constant discussions with partners and that ODD was the key to a deal with those partners.

Yet here we are, still in a position where we can easily run out of funds in only a few weeks/months but still chasing the next rainbow.

I think criticism of the way the company has been run is fair and justified. All I want is to see tangible progress being delivered. I want to know that the partners that the board are engaging with are willing to take the same risks as the rest us to find a way to combat this dreadful disease.

Don't you want to know why they are not yet willing to step out of the shadows and give us backing or what it will take for them to do that? Don't you want transparency from the people who are spending your money? I'm pretty sure I'm not the only one who does.

I wish you and your family all the best for the future and I really hope that the board can deliver something game changing soon so that the company and its assets don't go to the vultures.

"It would also be a blessing if FFX could receive news he is awaiting also :)"

Why thankyou OSD. I agree, it would be a blessing indeed....only if it's good news though

Littlened, I might if I knew what it was...and it was worthy of a response, of course.

Perhaps don't waste your time if it is just more unquestioning lapdog loyalty bs.

47 days have now passed since ODD ratification.

That's more than half of the 90 days they said the FDA evaluation process would take...and we still don't appear to have even a draft submission ready!

Where are the board!?

It basically feels like they have no serious partners to negotiate with and are just lurching from one fundraiser to the next based on some new criteria which they hope will validate the product enough to attract some kind of offer.

Meanwhile they just go back to their day jobs and we hear nothing for months.

Looks like the pumps over

There could be, if you actually came in to invest

Looks like the next P&D has just kicked off

"As a potential treatment for IPF, which is a rare disease, NXP002 is a likely candidate for Orphan Drug Designation"

That was from the results released on 3rd January 2024. It was over a year later (13th January 2025) before the draft application was finally ready. Check the RNS history if you don't believe me.

Many who were on here around that time will remember the talk on here about Telegram chatter of an unusual nature where someone purporting to be very close to the company is alleged to have expressed that it was strongly believed that ODD was essential for getting a deal and should be the focus of efforts going forward. I don't know if the person purporting to be that individual was genuine but given that the focus did switch to ODD afterwards, they seemed to be fairly clued up.

But if all that was known back then, why did it take so long to get the submission to draft? They must have known how long it would take. The fundraiser back in March 2024 was only ever going to last a few months.

The worry here is that history repeating itself. Have the board made any progress at all towards a draft FDA submission or are we going to have to continue to bankroll silence until May/June 2026?

"No confirmation, but the PR company would never say 'We will now submit"

It wasn't the PR company who used those words, it was Dan Gooding himself in the ODD confirmation RNS.

Thankyou for your words Wacca,

Despite the usual accusations, I am not a paid troll and do hold (and no, I won't sell up and shut up just because some locked in pump n dumpers don't like what I have to say).

I complain because the board never seems to deliver.

You will hopefully get confirmation of this at some point because If they ever do achieve what appears to be impossible for them and deliver tangible changes that result in a complete, prolonged and significant turnaround (and they don't manage to undo it shortly after)...then you will see a completely different and very happy me.

After everything that's happened though, I'm not going to hold my breath.

Still locked in?

...appears to have gone into hiding again!

Where are the partners?

Where is the FDA submission?

When are the public shareholders finally going to see some value added to the shareprice

You still locked in Littlened?

I suppose last friday's P&D didn't really get going before the desperate dumpers moved in?